Y-6 Sublingual Tablets for Acute Penetrating Artery Infarction
Clinical trial NCT07721545 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07721545
- Sponsor
- Neurodawn Pharmaceutical Co., Ltd.
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2026-08-31
- Primary completion
- 2028-02-28
- Enrollment
- 944
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.